Details for Patent: 8,314,083
✉ Email this page to a colleague
Which drugs does patent 8,314,083 protect, and when does it expire?
Patent 8,314,083 protects QUZYTTIR and is included in one NDA.
This patent has five patent family members in five countries.
Summary for Patent: 8,314,083
| Title: | Non-sedating antihistamine injection formulations and methods of use thereof |
| Abstract: | Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions therewith. |
| Inventor(s): | Du; Jie (Lansdale, PA) |
| Assignee: | JDP Therapeutics, Inc. (Lansdale, PA) |
| Application Number: | 12/829,857 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,314,083
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATMENT IN PATIENTS WITH CONCOMITANT ANGIOEDEMA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,314,083
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010266103 | ⤷ Sign Up | |||
| Canada | 2803987 | ⤷ Sign Up | |||
| European Patent Office | 2477634 | ⤷ Sign Up | |||
| Spain | 2616703 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2011003074 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
